#AIDS2022 En cours: Soirée des partenaires France sur comment le partenariat du Fonds Mondial participe de la résilience des systèmes de santé en contexte de crise. Modéré par Michel Kazatchkine, conseiller spécial de l’OMS-EUROPE

HAPPENING NOW!!! TRIO ART-OPTIMISATION satellite symposium IAC - the International AIDS Conference -room 517c/channel 4 Unitaid World Health Organization (WHO) Ezintsha University of Liverpool ANRS Maladies infectieuses émergentes @SiteAnrsCamroun DolPHIN 2 @transvihmi #AIDS2022

LIVE ! TRIO Symposium Treatment Optimisation: lessons from TRIO- ADVANCE, DOLPHIN2 AND NAMSAL- ANRS-12313 trial funded by UNITAID TRIO ART-OPTIMISATION IAC - the International AIDS Conference Unitaid World Health Organization (WHO) Ezintsha University of Liverpool ANRS Maladies infectieuses émergentes @SiteAnrsCamroun DolPHIN 2 @transvihmi #AIDS2022

Picture TRIO ART-OPTIMISATION IAC - the International AIDS Conference Unitaid World Health Organization (WHO) Ezintsha University of Liverpool ANRS Maladies infectieuses émergentes @SiteAnrsCamroun DolPHIN 2 @transvihmi #AIDS2022

TRIO SYMPOSIUM Move to session 2: Community engagement TRIO ART-OPTIMISATION IAC - the International AIDS Conference Unitaid World Health Organization (WHO) Ezintsha University of Liverpool ANRS Maladies infectieuses émergentes @SiteAnrsCamroun DolPHIN 2 @transvihmi #AIDS2022

TRIO SYMPOSIUM Live!ĺĺ Transition from clinical trial to national programme TRIO ART-OPTIMISATION IAC - the International AIDS Conference Unitaid World Health Organization (WHO) Ezintsha University of Liverpool ANRS Maladies infectieuses émergentes @SiteAnrsCamroun DolPHIN 2 @transvihmi #AIDS2022

TRIO SYMPOSIUM presentation going on!!! Picture TRIO ART-OPTIMISATION IAC - the International AIDS Conference Unitaid World Health Organization (WHO) Ezintsha University of Liverpool ANRS Maladies infectieuses émergentes @SiteAnrsCamroun DolPHIN 2 @transvihmi #AIDS2022

TRIO SYMPOSIUM Closing remarks!! ,TRIO ART-OPTIMISATION IAC - the International AIDS Conference Unitaid World Health Organization (WHO) Ezintsha University of Liverpool ANRS Maladies infectieuses émergentes @SiteAnrsCamroun DolPHIN 2 @transvihmi #AIDS2022

Thank you 🙏 very much to joined TRIO ART-OPTIMISATION during the satellite symposium IAC - the International AIDS Conference Unitaid World Health Organization (WHO) Ezintsha University of Liverpool ANRS Maladies infectieuses émergentes @SiteAnrsCamroun DolPHIN 2 @transvihmi

HAPPENING NOW At Globalvillage. TRIO ART-OPTIMISATION IAC - the International AIDS Conference Unitaid World Health Organization (WHO) Ezintsha University of Liverpool ANRS Maladies infectieuses émergentes @SiteAnrsCamroun DolPHIN 2 @transvihmi #AIDS2022

People watts to learn

The #HIV response requires a bold champion to help avert millions of needlessly lost lives.   I cordially invite you, Justin Trudeau, to address the global HIV community at the #AIDS2022 closing ceremony to outline your vision for the HIV response at home and around the world.

💊 New comedications added to the HIV site Dronedarone (Antiarrhythmics) Apalutamide (Cancer therapies) Bempedoic acid, Icosapent ethyl, Omega-3 fatty acids (Lipid Lowering Agents) Omega-3 fatty acids [in multivitamins] (Herbals/Supplements/Vitamins) Tirzepatide (Anti-diabetics)

Join us on Thursday 11 May at this year’s #INTEREST for our special session. Francois Venter Ezintsha ANRS Maladies infectieuses émergentes Unitaid University of Liverpool

The Unitaid funded ART Optimization portfolio has produced great lessons on conducting clinical trials in Africa. Join us INTEREST Conference on 11 May at 18:00. aidsmap Ezintsha ANRS Maladies infectieuses émergentes University of Liverpool #INTEREST2023 #HIV #Mozambique

Unitaid’s ART optimization portfolio ensures end-to-end approach to tackle access barriers to new optimal ARV’s- Pamela Nawaggi from Unitaid INTEREST Conference Unitaid Ezintsha University of Liverpool Molly Namsaly

Nkuli Mashabane, clinical trialist extraordinaire, taking us through the ADVANCE trial planning. INTEREST Conference

Chief investigator Prof Saye Khoo is participating in Enabling the ecosystem to accelerate HIV treatment optimization: Reflecting on what’s worked, what hasn’t, and looking ahead at #IAS2023 discussing the successes in DolPHIN2 and TRIO

Earlier in May, Unitaid announced new estimates projecting US$7 billion in savings to health systems by 2030, resulting from the rapid and widescale implementation of a groundbreaking treatment for HIV, dolutegravir. Find out more: unitaid.org/news-blog/unit…